The Role of Behavioral Medicine in Reducing Opioid Use

This is a FDA REMS-compliant accredited CE activity

WATCH NOW!

FDA Greenlight: Now Available to More Patients With DMD!

Explore the Latest in Diagnosis and Management Strategies

START LEARNING!

Celebrating 25 Years of CME!

Enhancing Medical Education One Program at a Time

Start Learning!

Weight Management in T2D

Breaking Barriers to Advance Clinical Practice

BEGIN MODULE!

Ask the Experts

The Role of Immunotherapy in Advancing the Treatment of HCC and BTC

Choose a time that fits your schedule!

Treatment Implications for the Present and Future

Evolutions in the Management of Duchenne Muscular Dystrophy (DMD)

START LEARNING!

The Role of Behavioral Medicine in Reducing Opioid Use

This is a FDA REMS-compliant accredited CE activity

WATCH NOW!

FDA Greenlight: Now Available to More Patients With DMD!

Explore the Latest in Diagnosis and Management Strategies

START LEARNING!

Celebrating 25 Years of CME!

Enhancing Medical Education One Program at a Time

Start Learning!

Weight Management in T2D

Breaking Barriers to Advance Clinical Practice

BEGIN MODULE!

LATEST EDUCATION

Microlearning: Durability of Gene Therapy

A Hematologic Emergency: Would You Miss iTTP?

The Role of Behavioral Medicine in Reducing Opiod Use

The Role of Behavioral Medicine in Reducing Opioid Use

Understanding PNH and Other Complement-mediated Hematologic Disorders

Current and Emerging Treatment Options in PNH

Microlearning: Uncontrolled DOAC-related Bleeding: Clinical Challenges, Unmet Needs

The Role of the Radiologist in the Multidisciplinary Management of Bronchiectasis

NTM-LD: Improving Diagnosis, Individualized Treatment, and Adherence

VIEW ALL EDUCATION

REQUEST A LIVE/VIRTUAL MEETING!

The France Foundation offers nationwide Grand Rounds on a variety of topics. Please click below to learn more and to request a program at your healthcare facility.

HEMATOLOGY

NEUROLOGY

ONCOLOGY

PSYCHIATRY

PULMONARY

Providers Educated

Accredited Activities

Hours of Instruction

Founded

HAPPY CLIENTS

What actually we do

The Role of Behavioral Medicine in Reducing Opioid Use

FDA Greenlight: Now Available to More Patients With DMD!

Celebrating 25 Years of CME!

Weight Management in T2D

Ask the Experts

Treatment Implications for the Present and Future

The Role of Behavioral Medicine in Reducing Opioid Use

FDA Greenlight: Now Available to More Patients With DMD!

Celebrating 25 Years of CME!

Weight Management in T2D

LATEST EDUCATION

REQUEST A LIVE/VIRTUAL MEETING!

Advances in the Therapeutic Management of PNH (Paroxysmal Nocturnal Hemoglobinuria)

Addressing the Unmet Needs in Myelofibrosis Management

Improving the Management of Patients with Duchenne Muscular Dystrophy: Emerging Evidence and Treatment Strategies

Advances in the Diagnosis, Assessment, and Therapeutic Management of Biliary Tract Cancers: What Clinicians Need to Know About the MDM2/p53 Pathway

A Continued Focus on Cognitive Impairment Associated with Schizophrenia (CIAS): The Latest Updates on Pathophysiology, Burden of Disease, & Clinical Management

Addressing Negative Symptoms and Cognitive Impairment Associated with Schizophrenia: A Focus on Digital Therapeutics

Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF

HAPPY CLIENTS

Search

Search Education

Latest Education

Login

The Role of Behavioral Medicine in Reducing Opioid Use

FDA Greenlight: Now Available to More Patients With DMD!

Celebrating 25 Years of CME!

Weight Management in T2D

Ask the Experts

Treatment Implications for the Present and Future

The Role of Behavioral Medicine in Reducing Opioid Use

FDA Greenlight: Now Available to More Patients With DMD!

Celebrating 25 Years of CME!

Weight Management in T2D

LATEST EDUCATION

REQUEST A LIVE/VIRTUAL MEETING!

Advances in the Therapeutic Management of PNH (Paroxysmal Nocturnal Hemoglobinuria)

Addressing the Unmet Needs in Myelofibrosis Management

Improving the Management of Patients with Duchenne Muscular Dystrophy: Emerging Evidence and Treatment Strategies

Advances in the Diagnosis, Assessment, and Therapeutic Management of Biliary Tract Cancers: What Clinicians Need to Know About the MDM2/p53 Pathway

A Continued Focus on Cognitive Impairment Associated with Schizophrenia (CIAS): The Latest Updates on Pathophysiology, Burden of Disease, & Clinical Management

Addressing Negative Symptoms and Cognitive Impairment Associated with Schizophrenia: A Focus on Digital Therapeutics

Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF

HAPPY CLIENTS

Search